Evan Norton is Divisional Vice President and leads Abbott Ventures (AVI) based in Abbott Park, Illinois.  He joined AVI in 2010.  Previously, he was a Principal with ONSET Ventures focused on medical technology investing.  He has a diverse background of operating experience in medical technology including the endoscopy, diabetes and ear, nose and throat markets having worked for Stryker Endoscopy, J&J LifeScan and Acclarent.  

 In addition to his medical device experience, Evan worked for Compaq Computer Corporation's Strategic Investments group, the Investment Banking Group at J.P. Morgan Chase & Co and in the consulting practice at PriceWaterhouseCoopers.

Evan holds an MBA degree from the J.L. Kellogg Graduate School of Management and a BBA in Finance from Texas A&M University.  He currently serves on the Innovation and New Ventures Advisory Board at Northwestern.

• MBA, 2002, Northwestern University
• B.A., 1996, Finance, Texas A&M University, cum laude

• Divisional Vice President, Abbott Ventures, INC., 2010-present
• Principal, Onset Ventures, 2007-2010
• Marketing Manager, Acclarent, INC., 2007-2007
• Marketing Manager, Lifescan, INC., 2003-2007
• Product Manager, Stryker Corporation, 2002-2003
• Strategic Investments/Corporate Development Intern, Compaq Computer Corporation, 1-2001
• Global Investment Banking Associate/Analyst, JPMorgan Chase, 1998-2000
• Management Consultant, Pricewaterhousecoopers LLP, 1996-1998

Medical Technology Financing and Commercialization (HCAK-611-0)
This course offers students an experiential learning opportunity to work directly in the commercialization and fundraising process for innovative, pre-commercial medical technologies, to include devices, diagnostics, services and software solutions. The insights from this hands-on course will be most beneficial to students with an interest in entrepreneurship, start-ups, product design, early stage financing and product marketing. Students will be placed on three-to-four member teams based on their skills, experience and project interests. Each team will function as members of the executive team working with select Northwestern tech transfer companies curated by Northwestern's INVO (Innovation and New Ventures Office). Each company will present their technology on the first day of class, after which students will rank their top choices and will be matched by the faculty to meet top preferences. Once matched, students will work with their respective companies to build a complete investor deck that will be delivered to a panel of industry and finance experts at the end of the quarter. Each class includes a faculty lecture and guest lecture in an effort to bring real world experiences and perspectives to each topic. Since its inception, this course has produced companies that competed in and won prestigious business plan competitions. It has also graduated several technologies/companies that are now FDA cleared and commercially available.

Note: This course may not be dropped after the first week of the quarter.

Field Study (HCAK-498-0)
Field Studies include those opportunities outside of the regular curriculum in which a student is working with an outside company or non-profit organization to address a real-world business challenge for course credit under the oversight of a faculty member. This course is for 1 credit unit. Please note: Professor Pete McNerney also oversees Healthcare Entrepreneurship projects under this course title.

Field Study (ENTR-498-5)
Field Studies include those opportunities outside of the regular curriculum in which a student is working with an outside company or non-profit organization to address a real-world business challenge for course credit under the oversight of a faculty member.